Legal & General Group PLC Prelude Therapeutics Inc Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 962 shares of PRLD stock, worth $913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
962
Previous 962
-0.0%
Holding current value
$913
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PRLD
# of Institutions
59Shares Held
30.4MCall Options Held
6.4KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$10.4 Million0.38% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$9.62 Million0.14% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$1.02 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.03MShares$977,7390.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$959,8720.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $34.6M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...